PROCARE PHARMACY DIRECT, L.L.C.

Procare Pharmacy Direct, L.L.C. specializes in the manufacturing and distribution of specialized pharmaceutical doses and compounded medications for federal healthcare programs. Their core capabilities center on precision pharmaceutical preparation, including the formulation and packaging of single-dose and patient-specific therapeutics under cGMP standards. The company demonstrates technical expertise in sterile and non-sterile compounding, drug stability management, and regulatory-compliant labeling for controlled substances. Their focus on tailored pharmaceutical dosing—evidenced by awards for medications such as FILSPARI and customized pharmaceutical doses—positions them as a niche provider of individualized treatment solutions, particularly for complex or rare clinical needs. Key differentiators include agile supply chain responsiveness, adherence to FDA and USP guidelines, and end-to-end control over manufacturing and delivery workflows. The contractor maintains a consistent and deep relationship with the Department of Veterans Affairs, delivering critical medication products that support veteran healthcare programs. Their work for the VA centers on ensuring timely access to specialty pharmaceuticals, including those requiring precise dosing regimens or unique formulation parameters, aligning with VA’s mission to provide personalized, high-quality care to enrolled veterans. Procare Pharmacy Direct operates primarily within NAICS 325412, which encompasses the manufacturing of pharmaceutical preparations, indicating a focus on finished dosage forms rather than bulk active ingredients. This vertical specialization enables them to serve the growing demand for customized, patient-centric therapies within government healthcare systems, particularly where standard commercial products are insufficient. As a limited liability company headquartered in Monroeville, Pennsylvania, Procare Pharmacy Direct functions as a small, focused manufacturer with no federal certifications on record. Their geographic footprint is centered in the Northeast, with operations designed to support federal supply chains requiring reliable, compliant pharmaceutical production and distribution.